Possible connection between osteoarthritis and cardiovascular disease
Turkiewicz, A.; Englund, M.
Lakartidningen 111(21): 932-933
2014
ISSN/ISBN: 0023-7205 PMID: 24946496 Document Number: 673354
Document emailed within 1 workday
Related Documents
DeRossi, S.S.; Sollecito, T.P. 2012: The oral-medical disease connection: pregnancy, cardiovascular disease, and diabetes Compendium of Continuing Education in Dentistry 33(6): 406Blacher, J.; Ducimetière, P.; Safar, M. 1999: Homocysteine and cardiovascular disease: what is the connection? Presse Medicale 28(31): 1717-1722
Bijlsma, J.W.J. 2004: Milk consumption and osteoarthritis: a doubtful connection Clinical and Experimental Rheumatology 22(4): 387-388
Dougados, M. 2004: Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis Journal of Rheumatology. Suppl 70: 66-69
Barkai, L.; Madácsy, L.; Vámosi, I. 1992: Connection between microalbuminuria and subclinical cardiovascular autonomic neuropathy in diabetic children Orvosi Hetilap 133(1): 29-33
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Turajane, T.; Wongbunnak, R.; Patcharatrakul, T.; Ratansumawong, K.; Poigampetch, Y.; Songpatanasilp, T. 2009: Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis Journal of the Medical Association of Thailand 92(Suppl 6): S19-S26
Queneau, P.; Lejeune, E.; Veysseyre, C.; Titoulet, M.; Vallat, M.P.; Carraz, M. 1978: Our experience with the determination of serum anti-alphastaphylolysins and antigammastaphylolysins during infectious osteoarthritis. a personal series of 53 staphylococcal osteoarthritis cases, 14 cases of osteoarthritis from various germs, 47 extra-articular staphylococcal infections and 500 control subjects Revue du Rhumatisme et des Maladies Osteo-Articulaires 45(5): 325-333
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Thorogood, M. 1993: Anticonceptivos orales y enfermedad cardiovascular - Oral contraceptives and cardiovascular disease Beneficios y Riesgos de la Anticoncepcion Oral. Simposio (Caracas 1992-11) 9: 19-29
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Hawker, G.A. 2019: Osteoarthritis is a serious disease Clinical and Experimental Rheumatology 37 Suppl 120(5): 3-6
Taliercio, J.J. 2010: Anemia and chronic kidney disease: what's the connection? Journal of Family Practice 59(1): 14-18
Katona, G. 1984: Osteoarthritis--an inflammatory disease? International Journal of Tissue Reactions 6(6): 453-461
Avouac, B.; Maheu, E.; Sallière, D.; Charpak, Y.; Le Loet, X. 1990: Social impact of osteoarthritis. Risk/benefit--cost/effectiveness ratio of osteoarthritis treatments Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(9): 37s-43s
Zak, M.Y.; Klymenko, M.O.; Iakovenko, N.O.; Grischenko, G.V. 2019: Medico-social value of osteoarthritis. secondary prevention and treatment of osteoarthritis in comorbidity with chronic gastritis Wiadomosci Lekarskie 72(5 Cz 2): 1064-1067
Burkman, R.T. 1994: Noncontraceptive effects of hormonal contraceptives: Bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1569-1575
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453